CELEBRATING 10 YEARS OF INNOVATION
UPCOMING EVENTS
Uniting the Key People to Drive & Foster Ophthalmic Innovation
UPCOMING EVENTS
Uniting the Key People to Drive & Foster Ophthalmic Innovation
LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
MIGS Minus One: What’s Next?
With Alcon’s voluntary withdrawal in late August of the CyPass MicroStent due to safety concerns, many have been wondering how the rest of the class ...
Glaukos and STAAR Drive OIS Index into Record Territory
The OIS Index of ophthalmic stocks surged to new highs in August, driven by two of the highest-weighted stocks in the index. The OIS Index ...
First US-Approved Nerve Growth Factor is for the Eye
In the use of biological agents for treatment of eye disease, the back of the eye has been pretty much the sole domain thanks to ...
Novartis’ Guerard Shares Plans for Brolucizumab, Lucentis, Gene Therapy, and FocalView App
Coming off the positive feedback at the American Society of Retina Specialists meeting to trial results of the investigative anti-VEGF agent brolucizumab, Frederic Guerard, Novartis’ ...
Gene Therapy Treatments Are Filling Some Companies’ Pipelines
Major pharma companies in ophthalmology aren’t the only ones making plays in the gene therapy space, as we reported last week. Mid-size and small companies ...
OIS Index Lags Market Benchmarks in July
The OIS Index of ophthalmic stocks declined by 1.1% in July, against a strong overall market backdrop. During the month, the overall US stock market ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.